Clinical Trials Browser

Phase 1/2 × mocetinostat × Other hematologic neoplasm × Clear all

NCT00324220 2015-07-01

A Phase I/II Study of MGCD0103 With Azacitidine in Patients With High-Risk Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia

Phase 1/2 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute